PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Pharmaceutical Institute, Pharmaceutical & Medicinal Chemistry, University of Bonn, An der Immenburg 4, 53121, Bonn, Germany), E-mails.\', \'Present address: Pharmaceutical Institute, Pharmaceutical Chemistry, Eberhard-Karls-University Tübingen, Auf der Morgenstelle 8, 72076, Tübingen, Germany.\', \'Institute for Virology and Immunobiology, Julius-Maximilians-University Würzburg, Versbacher Strasse 7, 97078, Würzburg, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/anie.202016961
?:hasPublicationType
?:journal
  • Angewandte Chemie (International ed. in English)
is ?:pmid of
?:pmid
?:pmid
  • 33655614
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Targeting the Main Protease of SARS-CoV-2: From the Establishment of High Throughput Screening to the Design of Tailored Inhibitors.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33655614>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33655614>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all